AirCurveTM 10 CS PaceWaveTM Support

  • With ResMed, your patients won’t need to walk the therapy journey alone. We’re here to offer help and support along the way, so they can get the most out of their therapy.

    AirCurveTM 10 CS PaceWaveTM Product Page

Reference

ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.